Symptoms Associated with Chemotherapy-Induced Peripheral Neuropathy

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

August 15, 2024

Conditions
Chemotherapy-induced Peripheral NeuropathyBreast CancerBreast Cancer Female
Interventions
OTHER

European Organization for Research and Treatment of Cancer-Chemotherapy Induced Peripheral Neuropathy (EORTC-CIPN20) questionnaire

"It consists of a total of 20 items each is scored from 1: not at all to 4: very much in a 4-point Likert scale. Individuals are requested to fill out by considering their last week. Sensory, motor, and autonomic subscales are reported within its constructs. A total of 9, 8, and 3 items are referred to as sensory, motor, and autonomic disturbances, respectively"

Trial Locations (1)

35620

Bakircay University Çiğli State and Training Hospital, Department of Medical Oncology, Izmir

All Listed Sponsors
lead

Izmir Bakircay University

OTHER

NCT06352567 - Symptoms Associated with Chemotherapy-Induced Peripheral Neuropathy | Biotech Hunter | Biotech Hunter